From research to industry
The French Alternative Energies and Atomic Energy Commission (CEA) is a key player in research, development and innovation.
Discover the main research areas on which the CEA works.
Find the latest scientific and institutional news of the CEA.
The CEA publishes various scientific and technical periodicals and videos. Through them, you can discover the CEA’s major research topics and the latest technological innovations produced by its laboratories.
The CEA Research News is a newsletter bringing to your knowledge the most impacting scientific and societal advances and impacts enabled by major European research projects carried by CEA and which are covering the main priorities of the European Union.
Article | Press release | Health ＆ life sciences | Diagnosis and innovative treatment | Diseases | Cellular mechanisms
The CEA has developed an immunization approach against HIV, based on a new delivery system, lipid nanoparticles Lipidots. Lipidots transport and deliver the viral protein, p24, essential antigen in HIV vaccines, combined with the CpG, an immunostimulatory agent. This system enhances the immune response to the protein and possibly the effectiveness of a future vaccine using this technology.
According to UNAIDS statistics, since the first HIV cases were discovered, more than 35 years ago, 78 million people have been infected with HIV and 35 million have died of the virus. The CEA is involved in the research and development of therapeutic and preventive approaches in the fields of infectious diseases, including AIDS.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.